Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07055867 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Epidemiological and Clinical Characteristics of Mpox Outbreak in Equateur, the DR Congo (Part1)

StatusEnrolling by Invitation
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 9, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
The goal of this observational study is to characterize the clinical features of the 2024 mpox outbreak in Equateur Province of DRC and to identify associated risk factors. The main question it aims to answer is: * What are the clinical features of the 2024 mpox outbreak in Equateur Province of DRC? * What are the associated risk factors of the 2024 mpox outbreak? Participants which has mpox like symptoms will answer mpox investigations related questions and be collected skin lesions and whole blood samples.
Trial Details
NCT Number NCT07055867
Lead Sponsor Osaka Metropolitan University
Collaborators: Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo
Conditions
(from sponsor)		 Mpox (Monkeypox)
Related terms Mpox, Monkeypox
Enrollment 122 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov